跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRIVIACT brivaracetam 50mg/5mL injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
BRIVIACT brivaracetam 50mg/5mL injection vial
Approved
STANDARD
BRIVIACT brivaracetam 50mg/5mL injection vial
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
3d1c2b0e748c5ee7
Company
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Type
Standard
Approval Details
Approval Id
3d1c2b0e748c5ee7
Product Name
BRIVIACT brivaracetam 50mg/5mL injection vial
Artg Id
243795
Artg Name
BRIVIACT brivaracetam 50mg/5mL injection vial
Sponsor
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Company Detail Path
/organization/ucb-australia-pty-ltd
Artg Date
2016-08-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d9e7fb5d206625c5f0ec3d78923d319d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/e92f971dcb54a0d63b022065de8060a1.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
3d1c2b0e748c5ee7
Type
Standard
Back to TGA Approvals
